These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7455927)

  • 21. [Transplacental blastomogenic action of n-propyl-nitrosourea in BD rats].
    Ivankovic S; Zeller WJ
    Arch Geschwulstforsch; 1972; 40(2):99-102. PubMed ID: 5081909
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of zinc acetate to reduce ethylenethiourea-induced fetal anomalies in rats.
    Khera KS; Shah BG
    Toxicol Appl Pharmacol; 1979 Apr; 48(2):229-35. PubMed ID: 473172
    [No Abstract]   [Full Text] [Related]  

  • 23. Tellurium hydrocephalus: distribution of tellurium-127m between maternal, fetal, and neonatal tissues of the rat.
    Agnew WF; Fauvre FM; Pudenz PH
    Exp Neurol; 1968 May; 21(1):120-31. PubMed ID: 5691955
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrastructural variations of the rat fetal adrenal cortex after maternal bilateral adrenalectomy and exogen glucocorticoid administration.
    Machin C; Sierra J; Diaz B; Rua C
    Acta Biol Hung; 1995; 46(1):87-98. PubMed ID: 8714766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of transplacentally induced teratogenic and carcinogenic effects in rabbits treated with N-nitroso-N-ethylurea.
    Fox RR; Meier H; Bedigian HG; Crary DD
    J Natl Cancer Inst; 1982 Dec; 69(6):1411-7. PubMed ID: 6958914
    [No Abstract]   [Full Text] [Related]  

  • 26. [The transplacental transit and action of ceftazidime on the fetus in an experiment on animals at different times of the pregnancy].
    Kasabulatov NM; Sheveleva GA; Voropaeva SD
    Eksp Klin Farmakol; 1994; 57(5):29-32. PubMed ID: 7696899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inheritance of susceptibility and resistance to the teratogenic effect of 1-ethyl-1-nitrosourea in inbred strains of mice.
    Diwan BA; Meier H
    Teratology; 1974 Feb; 9(1):45-9. PubMed ID: 4812357
    [No Abstract]   [Full Text] [Related]  

  • 28. [Distribution of lead in fetal rat tissue at different days of pregnancy].
    Zhang H; Bai X; Zheng X
    Wei Sheng Yan Jiu; 1999 Mar; 28(2):88-90. PubMed ID: 11939012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell sensitivity to transplacental carcinogenesis by N-ethyl-N-nitrosourea is greatest in early post-implantation development.
    Donovan PJ
    Mutat Res; 1999 Jun; 427(1):59-63. PubMed ID: 10354502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of recombinant human stem cell factor (rhSCF) and granulocyte-colony stimulating factor (rhG-CSF) to maternal and fetal rhesus monkeys (Macaca mulatta).
    Tarantal AF; Cowan MJ
    Cytokine; 1999 Apr; 11(4):290-300. PubMed ID: 10328868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplacental and postnatal ethylnitrosourea-induced leukemia and neurogenic tumors in Donryu rats.
    Takeda Z; Urano Y
    Kobe J Med Sci; 1981 Jun; 27(3):121-37. PubMed ID: 7265822
    [No Abstract]   [Full Text] [Related]  

  • 32. Placental transfer of the hypolipidemic drug, clofibrate, induces CYP4A expression in 18.5-day fetal rats.
    Simpson AE; Brammar WJ; Pratten MK; Cockcroft N; Elcombe CR
    Drug Metab Dispos; 1996 May; 24(5):547-54. PubMed ID: 8723735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of maternal administration of vigabatrin during late gestation on fetoplacental amino acid profile in the mouse.
    Abdulrazzaq YM; Padmanabhan R; Bastaki SM; Ibrahim A; Nurulain M; Shafiullah M
    Reprod Toxicol; 2005; 20(4):549-60. PubMed ID: 15927444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy.
    Ogawa T; Kuwagata M; Hori Y; Shioda S
    Toxicol Lett; 2007 Nov; 174(1-3):18-24. PubMed ID: 17900830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition and recovery of maternal and fetal cholinesterase enzymes following a single oral dose of chlorpyrifos in rats.
    Ashry KM; Abu-Qare AW; Saleem FR; Hussein YA; Hamza SM; Kishk AM; Abou-Donia MB
    Arch Toxicol; 2002 Feb; 76(1):30-9. PubMed ID: 11875622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of nitrosamide-induced hydrocephali by ascorbic acid after prenatal administration of ethylurea and nitrite to rats].
    Ivankovic S; Preussmann R; Schmähl D; Zeller J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973 May; 79(3):145-7. PubMed ID: 4270220
    [No Abstract]   [Full Text] [Related]  

  • 37. Antenatal glucocorticoid therapy increase cardiac alpha-enolase levels in fetus and neonate rats.
    Tsuzuki Y; Takeba Y; Kumai T; Matsumoto N; Mizuno M; Murano K; Asoh K; Takagi M; Yamamoto H; Kobayashi S
    Life Sci; 2009 Oct; 85(17-18):609-16. PubMed ID: 19583970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal, neonatal, and long-term alterations in hepatic retinoid levels following maternal polychlorinated biphenyl exposure in rats.
    Morse DC; Brouwer A
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):175-82. PubMed ID: 7878673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal, but not fetal, administration of corticosteroids restricts fetal growth.
    Newnham JP; Evans SF; Godfrey M; Huang W; Ikegami M; Jobe A
    J Matern Fetal Med; 1999; 8(3):81-7. PubMed ID: 10338060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of fetal and placental metabolic pathways in response to maternal thyroid and glucocorticoid hormone excess.
    Shafrir E; Barash V; Zederman R; Kissilevitz R; Diamant YZ
    Isr J Med Sci; 1994 Jan; 30(1):32-41. PubMed ID: 8138395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.